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-dP/dt were monitored. MBF (mVmin/g) and coronary vascular resislance 
(CVR) was determined by fluorescent microspheres. Myocardial iNOS activ- 
ity (fmol//~g) was assayed by conversion of L-14C-arginlne to L-14C-citrulline 
and NO. Infarcted rabbits developed left ventdcular dysfunction; MBF in the 
surviving myccardium was significantly recfuced, iNOS Inhibition by SMT and 
AG significantly improved myocardial performance and increased MBF in 
infamted rabbits but not in sham animals, 
In conclusion the present study provides evidence that increased iNOS 
formation in MI contributes to myocardial dysfunction; selective modulation 
of this isozyme improves cardiac performance and increases MBF in the 
suwiving myccardium and may be beneficial in the treatment of the disease. 
5:15 
~ Medical Treatment With ACE-Inhibitors Prevents the 
Ischemia-lndoced Activation of  Protein Kinase C in 
Acute Myocardial Infarcl lon 
Ruth H. Strasser, Markus Dahlem, Martin Braun, Ulrike Oehl, 
Rather Marquetant. Univers,ty of Heidelberg, Germany 
In early myocardial ischemia ACE-inhibitorS have been shown to reduce 
compensatory cardiac hypertrophy and possibly to prevent myocardial re- 
modeling. An enzyme which may contribute to these processes might be 
protein kinase C (PKC). Early myocardial ischemia has been shown to in- 
duce an activation of PKC. The mechanisms leading to this activation are not 
known- 
To investigate, ifACE-inhibitors might modulate the ischemia-induced ac- 
tivation of PKC, isolated perfused rat hearts according to the method of Lan- 
geedorff were subjected to myocardial ischamia by stop of perfusion for 2.5 
min. In the ischemic hearts PKC activity increased in the plasma membranes 
(310 :l: 29 to 381:1:18 pmol/min/mg protein) with a concomitant reduction 
of the cytosolic PKC activity. This trenslocetion of PKC is s,+:ggestive of a 
rapid activation of PKC in myocardial ischamia, Prepedusion for 20 rain. 
with two different ACE-inhibitors, Enalapdlat and Ramipdlat (each 10 pg/ml), 
followed by a 2.5 min. episode of ischemia was able to completely prevent 
the ischamia.induced translocetion and activation of PKC. PKC activity beth 
in the particulate and in the cytosolic fraction remained completely unaltered 
after brief periods o! ischemia in the preoence of an effective ACE-inhibition. 
Similarly, pretreatment with Enalapdlat (25-50 pg/kg i.p.) for one week was 
also able to completely prevent an activation of PKC in acute myocardial 
infarction. 
These data demonstrate for the first time that ACE-inhibition pdor to my* 
ocardial ischemia can effectively prevent the ischemia-induce activation of 
PKC. Further studies have to show, if ACE-inhibitors mediate pert of their 
protective ffects via this newly characterized blockade of protein kinase C 
activation in the infarcted heart. 
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~ Exercise Hemodynamica in Patients Chronically 
Supported With a Latt Ventricular Device: Results of 
the EVADE Pilot Trial 
Brian Jaskl, Kelley Branch, John Gordon, Robert Adamson, 
Peter Hoagland, I_am/Favrot, Richard Maly, Walter Dembitsky. Sharp 
Memorial HOSp#a/, San Diego, CA 92123 
As a pilot for the Experience with LVAD with Exercise (EVADE) trial, 10 
patients implanted with the Thermo Cardiosystems LVAD (8 pneumatic, 2 
vented alectdc) were assessed (ran ± SD) 46 ± 25 days pest-implant with 
supine bicycle exercise. VAD rate (VR), Fick cardiac (CO) and VAD (VO) 
output, right atrial (RA), pulmonary artery (PA), wedge (PCW), and radial 
artedal (BP) pressures (ram Hg), mixed venous 02 content (PAsat), and 02 
consumption (02) were: 
HR VR BP RA PA 
Rest 87±12 82<-18 94<-13 6±4 17±3 
Exercise 108<-17 107±21 103:J: 13 12:E5 31 :J: 7 
PCW CO (I/m) VO (I/m) PAsat (%) O2(-cc/kg/m ) 
Resi" 5<-3 5.0 ± 1.2 5,4±0.9 67+5 2.8:1:0+4 
Exercise 14±8 7.8 <- 2.5 7.0<-1.4 39±10 8.2 d: 1.7 
With exercise, CO increased more than VO (p < 0.05) and Doppler-echo 
showed LV ejection through the native aortic valve. Peak upright treadmill 
exercise 02 was 14.6 4- 2.9 (p < 0.005 ~,  supine bike). Hemoglobin (Hgb) 
was 10.5:1:1.2. Plasma flee Hgb was not elevated in any patient. 
Thus: 1) Despite postoperative anemia, circulatory reserve allowed exer- 
cise compatible with activities of dally life associated with mederate levations 
in dght and left heart filing pressures. 2) The LV and LVAD operate as ssdos 
pumps at rest, but as parallel pumps at peak exercise when increased left 
heart filling pressure permits LV ejection through the native aortic valve. 3) 
O~ consumption was higher with upright readmill compared to supine bike 
exercise. 
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I "~ '~ Effec'l o f  Percuteneous Cardlopulmonary Support 
on Coronary Artery Row Velocity 
ToyoJi Nemoto, Kazuo Kimura, Tomoakl Shlmizu, Yasuyuki Mochfda, 
Masami Kosuge, Naomitsu Kujt, Toshiyuki Ishikawa, Naomichi Miyasaki, 
Osamu To~hikubo, Masao Ishii. Yokohama City University, Yokohama, 
Japan 
Purpose of this study was to assess the effect of PCPS on coronary artery 
flow velocity (CAFV) and its waveform, using intravascular Doppler guide 
wire. PCPS were performed as circulatory support for left main trunk (LMT} 
stsnting in two patients and as rosustation measures for bystander Cardio- 
pulmonary arrest in six patients with acute myocardial infarction. The CAFV 
was recorded in normal coronary artery without stenosis (> 25%) dudng 
pump on and off, or during stepwise decrease in pump flow. In the patients 
(n = 2) with normal sinus rhythm after successful LMT stanting, the CAFV 
was normal dudng pump off, and PCPS increased it without changes in its 
waveform pettem. In the patient (n = 1) with ventdcular standstill, PCPS 
increased mean CAFV from zero to 55 cm/sec with non-pulsatile flow. In the 
patients (n = 5) undergoing circulatory-pulmonary resustation, native coro- 
nary flow under ventricular hythm during pump off indicated charactedstic 
findings, such as marked decrease in systolic antegrade flow, appearance 
of abnormal broad systolic retrograde flow (SRF) and rapid deceleration of 
diastolic antegrade flow (DAF). Circulatory assist of PCPS increased mean 
CAFV and improved the efficient coronary circulation, which was indicated 
by OAF minus SRF. In conclusion, PCPS may increase coronary artery flow 
and improve abnormal CAFV waveform impairecl by cardiac dete,-ioralion. 
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~ Temporary Mechanical Support Wilh the BVS 5000 
Assist Device During Treatment of  Acute Viral 
Myocarditi.s 
Daniel Mare,i, Hi,el Laks, Abbas Ardshali, Bram Amsel, Gregory Couper, 
G. Kimble Jett, Aivaro Galindo, Davis C. Ddnkwater. UCLA Medical Center, 
Los Angeles, California 
Ventricuiar support with the BVS 5000 (Abiomed) has been used as tempe- 
rary circulatory assist for the failing heart. Our purpose is to summarize four 
cases illustrating the role of mechanical unloading in acute myocarditis. 
Four patients aged 16-33 y.o. presented with CHF 4-20 days after a 
flu-like syndrome. All patients were in severe cerdiogenic shock :t: renal and 
liver dysfunction. EF ranged from 5-26%. Indications for ventdcular assist 
were failure of maximal medical treatment with _> two inotmpes :t: IABP. 
Myocardial biopsy revealed acute myocarditis in three patients and severe 
edema in one despite a charactsdstic linical course, Two patients received 
immunotharapy with OKT3. Biventdcular assist was used in three patients 
and left ventricular assist only was used in one. Mean support time was 
0.3 days (7-11). All patients had recovery of myocardial function and were 
discharged from the hospital in good condition. 
Conclusion: The BVS 5000 device provides a safe, simple, and effective 
method to support the circulation during acute myocarditis. We hypothesize 
that this may facilitate myocardial recovery by decompressing the distended 
ventricle. Ventdcular assist devices should be used eady in the presence of 
detsdoration on maximal medical therapy. 
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~ Computer Model Predicts Alterat ions in Stroke 
Volume After Cardiomyoplasty 
Rashid M. Ahmad, Brian J. DeGuzman, David B. Lautz, Frederick Y. Chert, 
Rite G. Laurence, Lawrence H. Cohn. Brigham & Women's Hospital, 
Goston, MA 02115 
We developed a computer model to predict alterations in SV following dy- 
namic cardiomyoplasty (DCM). The model examined the effects of LV size 
and shape, and degree of latissimus dorei muscle tiber shortening (LDMFS) 
to predict changes in SV. The model provides an explanation as to why 
significant augmentation in SV has not been seen clinicaUy after DCM. Input 
